Hikma Pharmaceuticals (HIK:LSE) Annual Reports & Investor Relations Material

Overview

Hikma Pharmaceuticals PLC is a leading pharmaceutical company focused on the development, manufacturing, and marketing of generic and in-licensed pharmaceutical products. The company operates in three different segments, including Branded Pharmaceuticals, Generic Pharmaceuticals, and Injectable Pharmaceuticals, and offers a range of final dosage forms such as solid, semi-solid, liquid, and injectable products. With its strong industry expertise and diverse product portfolio, Hikma Pharmaceuticals PLC has established itself as a major player within the pharmaceutical sector.

Frequently Asked Questions

What is Hikma Pharmaceuticals's ticker?

Hikma Pharmaceuticals's ticker is HIK

What exchange is Hikma Pharmaceuticals traded on?

The company's shares trade on the LSE stock exchange

Where are Hikma Pharmaceuticals's headquarters?

They are based in London, England

How many employees does Hikma Pharmaceuticals have?

There are 5001-10,000 employees working at Hikma Pharmaceuticals

What is Hikma Pharmaceuticals's website?

It is hikma.com/home

What type of sector is Hikma Pharmaceuticals?

Hikma Pharmaceuticals is in the Healthcare sector

What type of industry is Hikma Pharmaceuticals?

Hikma Pharmaceuticals is in the Drug Manufacturers - Major industry

Who are Hikma Pharmaceuticals's peers and competitors?

The following five companies are Hikma Pharmaceuticals's industry peers:

- Advanz Pharma Corp

- Progenics Pharmaceuticals

- TherapeuticsMD

- Aerie Pharmaceuticals Inc

- Eli Lilly and Company